Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Financing Activities: 2016-2025

Historic Cash from Financing Activities for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to -$10.2 million.

  • Organogenesis Holdings' Cash from Financing Activities fell 508.65% to -$10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year increase of 370.87%. This contributed to the annual value of $27.6 million for FY2024, which is 602.03% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Cash from Financing Activities stood at -$10.2 million, which was down 3,444.10% from -$288,000 recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Cash from Financing Activities peaked at $33.6 million during Q4 2024, and registered a low of -$10.2 million during Q3 2025.
  • Over the past 3 years, Organogenesis Holdings' median Cash from Financing Activities value was -$1.7 million (recorded in 2024), while the average stood at $871,000.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first tumbled by 5,630.77% in 2023, then surged by 1,993.58% in 2024.
  • Organogenesis Holdings' Cash from Financing Activities (Quarterly) stood at -$917,000 in 2021, then tumbled by 104.47% to -$1.9 million in 2022, then increased by 5.23% to -$1.8 million in 2023, then soared by 1,993.58% to $33.6 million in 2024, then plummeted by 508.65% to -$10.2 million in 2025.
  • Its Cash from Financing Activities stands at -$10.2 million for Q3 2025, versus -$288,000 for Q2 2025 and -$2.1 million for Q1 2025.